The transition from preclinical development to clinical manufacturing is a crucial pivot point in the lifecycle of any new drug product. It’s also a step where many biotech companies run into challenges – from project delays and cost overruns, to operational snags and regulatory friction.  
In this webcast, we’ll explore key steps and strategies that can help biotech companies successfully navigate the critical shift from early-stage development to clinical manufacturing. Join us to learn about some of the most important best practices your product team should consider as you plan to make the leap from the bench to the clinic.